Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatast tablet phase II trial in bronchial asthma
CTR20131347Phase 2Active
- Sponsor
- Kaifeng Pharmaceutical Group Co., Ltd
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rupatadine in asthma (2 arms), sponsored by Kaifeng Pharmaceutical Group Co., Ltd. Primary endpoint: Change from baseline in weekly mean morning peak expiratory flow after 8 weeks of treatment. Started Nov 2013; status: active.
02
Drugs
rupatadine
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20131347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131347.